ARCHIVES

Individualized Cancer Vaccines Show 90% Survival at 6 Months

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Vaccine Increases PFS 146%, OS 60% In Phase II Clinical Trial

May 31, 2013

In Brief: Paul Rambaut Leaving NCI For NATO Position; Niederhuber New Cancer Commission Chairman

December 9, 1988

Sunitinib Prolongs Survival In Poor Prognosis, Study Finds

July 31, 2009

ACCC Presentations On Care In Community

March 27, 1981

Regulatory Agencies: Health Warnings Sought on Cigars

July 23, 1999

NCI considers allowing some centers to opt out of site visits.

March 19, 2004